Saliva Testing for High-Risk Human Papillomavirus Infection Oral Cavity and Pharynx Cancer

WithdrawnOBSERVATIONAL
0
Timeline

Start Date

August 31, 2025

Primary Completion Date

August 31, 2026

Study Completion Date

August 31, 2026

Conditions
Oropharyngeal Squamous Cell CarcinomaHuman Papillomavirus Infection
Interventions
GENETIC

Pre-Radiation Dental Evaluation/Sample Collection

Collection of saliva samples and mouth swabs and pre-cancer dental evaluation by study staff. Unstimulated saliva will be collected then a buccal swab sample will be obtained. Participants will be asked to rinse their mouth with water, wait 10 minutes, then 1-2 mL of unstimulated saliva will be captured into sterile centrifuge tube. Next, a buccal swab sample will be collected using a sterile cotton swab and immediately placed in a transport tube containing buffer (Tris with low EDTA)

OTHER

Pre-Study Visit

Collection of vital signs, medical history and current medications

GENETIC

Oral Medicine Consultation Visit/Sample Collection

Collection of saliva samples and mouth swab, complete oral medicine consultation by study staff. Unstimulated saliva will be collected then a buccal swab sample will be obtained. Participants will be asked to rinse their mouth with water, wait 10 minutes, then 1-2 mL of unstimulated saliva will be captured into sterile centrifuge tube. Next, a buccal swab sample will be collected using a sterile cotton swab and immediately placed in a transport tube containing buffer (Tris with low EDTA)

Sponsors
All Listed Sponsors
collaborator

InnoTech Precision Medicine

UNKNOWN

lead

Wake Forest University Health Sciences

OTHER

NCT06362421 - Saliva Testing for High-Risk Human Papillomavirus Infection Oral Cavity and Pharynx Cancer | Biotech Hunter | Biotech Hunter